Skip to Main Content

Paper Details

Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
Br J Haematol
33
2020
Author NameAffiliation
Robert A BrodskyJohns Hopkins University School of Medicine
  • 1 - 1

Datasets

Release 1.2